| Pharmaceutical active ingredients: |
| HydrochlorothiazideLisinopril |
| Available forms, composition and doses of Tobicor Plus: |
| Tablets; Oral; Hydrochlorothiazide 12.5 mg; Lisinopril 10 mgTablets; Oral; Hydrochlorothiazide 12.5 mg; Lisinopril 20 mg |
| Tobicor Plus medical category: |
| Human:Angiotensin-Converting Enzyme inhibitorsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09BA03 - Lisinopril and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Teva |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Prinzide | Hydrochlorothiazide; Lisinopril | Merck; Bristol-Myers Squibb; Mepha; Vianex |
| Secubar Diu | Hydrochlorothiazide; Lisinopril | Novartis; Sandoz |
| Sinorezid | Hydrochlorothiazide; Lisinopril | Eczacibasi; Sotex |
| Tensikey Complex | Hydrochlorothiazide; Lisinopril | Inkeysa |
| Tensopril D | Hydrochlorothiazide; Lisinopril | IVAX |
| Tonotensil D | Hydrochlorothiazide; Lisinopril | Chile Laboratorios |
| Vivatec Comp | Hydrochlorothiazide; Lisinopril | Merck |
| Vivazid | Hydrochlorothiazide; Lisinopril | Merck |
| Zestoretic | Hydrochlorothiazide; Lisinopril | AstraZeneca; Cana; Four Star; Zuellig Pharma |
| Zestoretic Mite | Hydrochlorothiazide; Lisinopril | AstraZeneca |